Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2009; Volume 197, Supplement 675
Joint meeting of The Slovenian Physiological Society, The Austrian Physiological Society and The Federation of European Physiological Societies
11/12/2009-11/15/2009
Ljubljana, Slovenia


CARDIAC RYANODINE RECEPTORS: A NOVEL THERAPEUTIC TARGET IN DIABETIC CARDIOMYOPATHY
Abstract number: L50

Bilginoglu1 Ayca, Zeydanli1 Esma N., Tuncay1 Erkan, Seymen1 Aytac A., Turan1 Belma

1Departments of Biophysics, Faculty of Medicine, Ankara University, Ankara, Turkey

Abnormal intracellular Ca2+ ([Ca2+]i) handling by the sarcoplasmic reticulum (SR) is a critical factor in the development of heart failure (HF). Excitation-contraction coupling is predominantly controlled by Ca2+ release from the SR via the ryanodine receptor (RyR2). Release of Ca2+ via RyR2 is induced by Ca2+ influx through L-type Ca2+ channels and is modulated by multiple factors, including phosphorylation of RyR2 by protein kinase A, calmodulin kinase II and FKBP12.6. Hyperphosphorylation of RyR2 induces Ca2+ leak during diastole, which can cause fatal arrhythmias and lead to HF. This makes RyR2 an important therapeutic target.

We studied and confirmed the defective [Ca2+]i signaling with both lower amplitude and slower kinetics of Ca2+ transients as well as the decreased SR Ca2+ load in diabetic rats. Furthermore we clearly established that these defects could be attributed to anomalous RyR2 behavior, as revealed by the spatio-temporal properties of Ca2+ sparks that especially exhibited slower kinetics. The reduced amount of RyR2 and FKBP12.6 levels and the PKA-dependent phosphorylation of RyR2 could be responsible for most of these observations. A lower SR Ca2+ load reinforced these defects in Ca2+ release channels.

We demonstrated that a beta-adrenergic receptor blocker, timolol treated diabetic rats exerted a protective action against anomalous Ca2+ homeostasis that was attributable to reduced RyR2 phosphorylation level, and recovery of protein levels of both RyR2 and FKBP12.6. Similar recoveries are also obtained by treating the diabetic rats with another beta-adrenergic receptor blocker, propranolol. We also showed that treatment of diabetic rats with these two beta-blockers restored the altered kinetic parameters of Ca2+ transients, depressed Ca2+ loading of SR and basal [Ca2+]i. It is concluded that a detailed understanding of the basic structure and function of RyR2 will provide us their involvement in heart diseases, and the development of drugs to prevent RyR2 malfunction.

(Supported by TUBITAK-SBAG-107S427 and SBAG-107S304, COST BM0602).

To cite this abstract, please use the following information:
Acta Physiologica 2009; Volume 197, Supplement 675 :L50

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE